Effect of ginger (Zingiber officinale) on inflammatory markers: A systematic review and meta-analysis of randomized controlled trials. (November 2020)
- Record Type:
- Journal Article
- Title:
- Effect of ginger (Zingiber officinale) on inflammatory markers: A systematic review and meta-analysis of randomized controlled trials. (November 2020)
- Main Title:
- Effect of ginger (Zingiber officinale) on inflammatory markers: A systematic review and meta-analysis of randomized controlled trials
- Authors:
- Morvaridzadeh, Mojgan
Fazelian, Siavash
Agah, Shahram
Khazdouz, Maryam
Rahimlou, Mehran
Agh, Fahimeh
Potter, Eric
Heshmati, Shilan
Heshmati, Javad - Abstract:
- Graphical abstract: Highlights: Ginger have anti-inflammatory cytokines properties. Ginger intake significantly decrease CRP, TNF-α serum levels, but not IL-6. Ginger efficiently act as an anti-inflammatory herbal complementary adjunct therapy. Abstract: The aim of this systematic review and meta -analysis was to investigate the efficacy of ginger supplementation on circulating levels of C-reactive protein (CRP), high sensitivity C-reactive protein (hs-CRP), tumor necrosis factor-alpha (TNF-α), soluble intercellular adhesion molecule (sICAM), and interleukin-6 (IL-6) concentrations in randomized controlled trials (RCTs). The search included PubMed-Medline, EMBASE, Scopus, Web of Science and Cochrane Library databases to identify randomized clinical trials on the effect of ginger supplementation on circulation levels of CRP, hs-CRP, IL-6, sICAM, and TNF-α published up until February 1st, 2020. We did not restrict articles based on language of publication. Standard mean differences and 95% confidence intervals were calculated for net changes in inflammatory mediators using a random-effects model. Sixteen RCTs comprising 1010 participants were found to be eligible for this meta -analysis. There was a significant reduction of circulating CRP (SMD: −5.11, 95% CI: −7.91, −2.30, I 2 = 98.1%), hs-CRP (SMD: −0.88, 95% CI: −1.63, −0.12, I 2 = 90.8%) and TNF-α levels (SMD: −0.85, 95% CI: −1.48, −0.21, I 2 = 89.4%) following ginger supplementation. However, meta -analysis results didGraphical abstract: Highlights: Ginger have anti-inflammatory cytokines properties. Ginger intake significantly decrease CRP, TNF-α serum levels, but not IL-6. Ginger efficiently act as an anti-inflammatory herbal complementary adjunct therapy. Abstract: The aim of this systematic review and meta -analysis was to investigate the efficacy of ginger supplementation on circulating levels of C-reactive protein (CRP), high sensitivity C-reactive protein (hs-CRP), tumor necrosis factor-alpha (TNF-α), soluble intercellular adhesion molecule (sICAM), and interleukin-6 (IL-6) concentrations in randomized controlled trials (RCTs). The search included PubMed-Medline, EMBASE, Scopus, Web of Science and Cochrane Library databases to identify randomized clinical trials on the effect of ginger supplementation on circulation levels of CRP, hs-CRP, IL-6, sICAM, and TNF-α published up until February 1st, 2020. We did not restrict articles based on language of publication. Standard mean differences and 95% confidence intervals were calculated for net changes in inflammatory mediators using a random-effects model. Sixteen RCTs comprising 1010 participants were found to be eligible for this meta -analysis. There was a significant reduction of circulating CRP (SMD: −5.11, 95% CI: −7.91, −2.30, I 2 = 98.1%), hs-CRP (SMD: −0.88, 95% CI: −1.63, −0.12, I 2 = 90.8%) and TNF-α levels (SMD: −0.85, 95% CI: −1.48, −0.21, I 2 = 89.4%) following ginger supplementation. However, meta -analysis results did not show any significant impact of ginger supplementation on IL-6 (SMD: −0.45, 95% CI: −1.29, 0.38, I 2 = 89.2%), and sICAM levels (SMD: −0.05, 95% CI: −0.36, 0.26, I 2 = 00.0%). This systematic review and meta -analysis of RCTs demonstrates a significant impact of ginger in lowering circulating CRP, hs-CRP and TNF-α levels. Large-scale RCTs are still needed to draw concrete conclusions about the effect of ginger on other inflammatory mediators. … (more)
- Is Part Of:
- Cytokine. Volume 135(2020)
- Journal:
- Cytokine
- Issue:
- Volume 135(2020)
- Issue Display:
- Volume 135, Issue 2020 (2020)
- Year:
- 2020
- Volume:
- 135
- Issue:
- 2020
- Issue Sort Value:
- 2020-0135-2020-0000
- Page Start:
- Page End:
- Publication Date:
- 2020-11
- Subjects:
- Ginger -- Inflammation -- C - reactive protein -- TNF-α -- IL-6
CRP C-reactive protein -- hs-CRP high sensitivity C-reactive protein -- TNF-α tumor necrosis factor-alpha -- sICAM soluble intercellular adhesion molecule -- IL-6 interleukin-6 -- SMD standardized mean difference -- CI confidence intervals -- CVD Cardiovascular disease -- NF-κB nuclear factor- kappa-B -- PPAR-γ peroxisome proliferator-activated receptor-gamma -- VCAM-1 Vascular cell adhesion molecule-1 -- PD peritoneal dialysis -- PGE2 prostaglandin E2 -- COX-2 cyclooxygenase-2 -- MCP-1 chemoattractant protein-1 -- MIPs migration inhibition proteins -- MAPK mitogen-activated protein kinase -- INF-γ Interferon gamma -- EGF Epidermal growth factor -- RCTs randomized controlled trials -- ROS Reactive oxygen sepsis
Cytokines -- Periodicals
571.844 - Journal URLs:
- http://www.sciencedirect.com/science/journal/10434666 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.cyto.2020.155224 ↗
- Languages:
- English
- ISSNs:
- 1043-4666
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3506.778000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 14269.xml